Scilex Holding (NASDAQ:SCLXW – Get Free Report) shares traded up 22.5% during trading on Friday . The company traded as high as $0.25 and last traded at $0.25. 6,513 shares traded hands during mid-day trading, an increase of 154% from the average session volume of 2,569 shares. The stock had previously closed at $0.20.
Scilex Price Performance
The stock has a 50 day moving average of $0.28 and a 200 day moving average of $0.31.
Scilex Company Profile
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
Further Reading
- Five stocks we like better than Scilex
- Business Services Stocks Investing
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Scilex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scilex and related companies with MarketBeat.com's FREE daily email newsletter.
